Blood–retinal barrier in hypoxic ischaemic conditions: Basic concepts, clinical features and management
暂无分享,去创建一个
E. Ling | C. Kaur | W. Foulds | E. A. Ling | C. Kaur | W. S. Foulds
[1] J. Marshall,et al. Hydraulic conductivity of fixed retinal tissue after sequential excimer laser ablation: barriers limiting fluid distribution and implications for cystoid macular edema. , 2001, Archives of ophthalmology.
[2] E. Chang,et al. Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[3] P. Leuenberger,et al. Glial reactivity, an early feature of diabetic retinopathy. , 2000, Investigative ophthalmology & visual science.
[4] M. Balda,et al. Tight junctions: molecular architecture and function. , 2006, International review of cytology.
[5] K. Hirschi,et al. Pericytes in the microvasculature. , 1996, Cardiovascular research.
[6] J. Lawrenson,et al. Contractile proteins in pericytes at the blood-brain and blood-retinal barriers , 2001, Journal of neurocytology.
[7] D. R. Anderson,et al. Sensitivities of ocular tissues to acute pressure-induced ischemia. , 1975, Archives of ophthalmology.
[8] Manju Patel,et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. , 2005, Ophthalmology.
[9] M. Reim,et al. Role of rheologic factors in patients with acute central retinal vein occlusion. , 1996, Ophthalmology.
[10] D. Guyer,et al. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease , 2006, Nature Reviews Drug Discovery.
[11] A. Weyrich,et al. Activated platelets signal chemokine synthesis by human monocytes. , 1996, The Journal of clinical investigation.
[12] H. Schatz,et al. Central retinal vein occlusion in young adults. , 1993, Survey of ophthalmology.
[13] M. Sanders. Vision and Circulation , 1977 .
[14] M Peduzzi,et al. [Blood viscosity and erythrocyte deformability in diabetic retinopathy]. , 1983, La Ricerca in clinica e in laboratorio.
[15] R. Nussenblatt,et al. Uveitis: Fundamentals and Clinical Practice , 1988 .
[16] H. Ahmadieh,et al. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.
[17] G. Chader,et al. Interphotoreceptor retinoid-binding protein (IRBP): a model protein for molecular biological and clinically relevant studies. Friedenwald lecture. , 1989, Investigative ophthalmology & visual science.
[18] J. Cunha-Vaz. The blood-retinal barriers , 1976, Documenta Ophthalmologica.
[19] M. Tarnawski,et al. Increased blood–brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor , 1998, Journal of neurocytology.
[20] G. Vrensen,et al. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations , 2000 .
[21] M. McKibbin,et al. Purtscher's and Purtscher-like retinopathies: a review. , 2006, Survey of ophthalmology.
[22] T. Chan-Ling,et al. Altered pericyte–endothelial relations in the rat retina during aging: Implications for vessel stability , 2006, Neurobiology of Aging.
[23] E. Voest,et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. , 1996, The Journal of clinical investigation.
[24] C. Toris,et al. Extravascular albumin concentration of the uvea. , 1990, Investigative ophthalmology & visual science.
[25] A. Reichenbach,et al. VEGF release by retinal glia depends on both oxygen and glucose supply , 2000, Neuroreport.
[26] L. Rizzolo,et al. Remodeling of junctional complexes during the development of the outer blood‐retinal barrier , 1997, The Anatomical record.
[27] W. Foulds,et al. The effects of total acute ischaemia on the structure of the rabbit retina. , 1978, Experimental eye research.
[28] G. Lutty,et al. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.
[29] J. Marshall,et al. Age-related variation in the hydraulic conductivity of Bruch's membrane. , 1995, Investigative ophthalmology & visual science.
[30] M. Melli,et al. Comparative evaluation of blood viscosity in diabetic retinopathy , 2004, International Ophthalmology.
[31] C. Brosnan,et al. Pathophysiologic effect of interleukin-1b in the rabbit retina. , 1990, The American journal of pathology.
[32] Y. Ogura,et al. Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium. , 1999, Investigative ophthalmology & visual science.
[33] S. Eaton,et al. Apical, basal, and lateral cues for epithelial polarization , 1995, Cell.
[34] Neil M Bressler,et al. Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. , 2007, Archives of ophthalmology.
[35] Peter Gehlbach,et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. , 2002, Investigative ophthalmology & visual science.
[36] Y. Ogura,et al. Platelets adhering to the vascular wall mediate postischemic leukocyte-endothelial cell interactions in retinal microcirculation. , 2004, Investigative ophthalmology & visual science.
[37] J D Gottsch,et al. Oxidative damage and age-related macular degeneration. , 1999, Molecular vision.
[38] W. Foulds,et al. The combined effects of light and acute ischemia on the structure of the rabbit retina: a light and electron microscopic study. , 1982, Investigative ophthalmology & visual science.
[39] Silvia Fischer,et al. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. , 2002, Brain : a journal of neurology.
[40] W. Foulds,et al. Effect of intravitreal hyaluronidase on the clearance of tritiated water from the vitreous to the choroid. , 1985, The British journal of ophthalmology.
[41] W. Foulds. Do we need a retinal pigment epithelium (or choroid) for the maintenance of retinal apposition? , 1985, The British journal of ophthalmology.
[42] G. Yancopoulos,et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. , 2001, Investigative ophthalmology & visual science.
[43] Y. Wang,et al. Strengthening tight junctions of retinal microvascular endothelial cells by pericytes under normoxia and hypoxia involving angiopoietin-1 signal way , 2007, Eye.
[44] Charles E. Riva,et al. Regulation of retinal blood flow in health and disease , 2008, Progress in Retinal and Eye Research.
[45] C. Pournaras,et al. Topographic variation of the choroidal watershed zone and its relationship to neovascularization in patients with age‐related macular degeneration , 2009, Acta ophthalmologica.
[46] N. Rao,et al. Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. , 2003, Investigative ophthalmology & visual science.
[47] M. Tsacopoulos,et al. Lactate released by Muller glial cells is metabolized by photoreceptors from mammalian retina , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[48] B Kirchhof,et al. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.
[49] A. Bill,et al. Control of retinal and choroidal blood flow , 1990, Eye.
[50] M. Norenberg,et al. Astrocytes in cerebral ischemic injury: Morphological and general considerations , 2005, Glia.
[51] B. Shin,et al. Colocalization of tight junction proteins, occludin and ZO-1, and glucose transporter GLUT1 in cells of the blood-ocular barrier in the mouse eye , 1998, Histochemistry and Cell Biology.
[52] W. Foulds,et al. The permeability of the posterior blood ocular barrier after xenon photocoagulation: a study using fluorescein labelled dextrans. , 1981, The British journal of ophthalmology.
[53] T. Davis,et al. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. , 2003, American journal of physiology. Heart and circulatory physiology.
[54] J. Huber,et al. Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. , 2004, American journal of physiology. Heart and circulatory physiology.
[55] D. R. Anderson,et al. Oxygen modulation of guanylate cyclase-mediated retinal pericyte relaxations with 3-morpholino-sydnonimine and atrial natriuretic peptide. , 1997, Investigative ophthalmology & visual science.
[56] J. Stone,et al. Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier. , 1992, Investigative ophthalmology & visual science.
[57] E. Ling,et al. Blood–retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration , 2007, The Journal of pathology.
[58] F. Sendo,et al. Vascular hyperpermeability induced by tumor necrosis factor and its augmentation by IL-1 and IFN-gamma is inhibited by selective depletion of neutrophils with a monoclonal antibody. , 1990, Journal of immunology.
[59] A. Bird,et al. Treatment of chronic macular edema with acetazolamide. , 1988, Archives of ophthalmology.
[60] D TOUSSAINT,et al. Retinal vascular patterns. IV. Diabetic retinopathy. , 1961, Archives of ophthalmology.
[61] P. Kaiser,et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. , 2007, American journal of ophthalmology.
[62] P. Dore‐Duffy,et al. Role of the CNS microvascular pericyte in the blood‐brain barrier , 1998, Journal of neuroscience research.
[63] J. Pederson. Chapter 113 – Fluid Physiology of the Subretinal Space , 2006 .
[64] E. Rodriguez-Boulan,et al. Morphogenesis of the polarized epithelial cell phenotype. , 1989, Science.
[65] R. Castroviejo. Experimental Detachment of the Retina , 1934 .
[66] Á. Almeida,et al. Roles of nitric oxide in brain hypoxia-ischemia. , 1999, Biochimica et biophysica acta.
[67] D. Bok,et al. Practical Remarks on Gout, Rheumatic Fever, and Chonic Rheumatism of the Joints; Being the Substance of the Croonian Lectures for the Present Year, Delivered at the College of Physicians , 1844, Edinburgh Medical and Surgical Journal.
[68] David J. Wilson,et al. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. , 1995, Ophthalmology.
[69] J. Stone,et al. Role of astrocytes in the control of developing retinal vessels. , 1997, Investigative ophthalmology & visual science.
[70] W. Foulds. The retinal-pigment epithelial interface. , 1979, The British journal of ophthalmology.
[71] M. Forbes,et al. Ultrastructure of pericytes in mouse heart. , 1977, The American journal of anatomy.
[72] You-xin Chen,et al. Hepatocyte growth factor and its role in the pathogenesis of retinal detachment. , 2004, Investigative ophthalmology & visual science.
[73] S. Schaeffer,et al. The structural basis of the inner blood-retina barrier in the eye of Macaca mulatta. , 1987, Investigative ophthalmology & visual science.
[74] P. Heiduschka,et al. Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. , 2007, American journal of ophthalmology.
[75] Jerry Sebag,et al. The Vitreous , 1989, Springer New York.
[76] C. Forbes,et al. Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. , 1983, The British journal of ophthalmology.
[77] Sims De. Recent advances in pericyte biology--implications for health and disease. , 1991 .
[78] M. Lavail,et al. Histochemical demonstration of spatial heterogeneity in the interphotoreceptor matrix of the rat retina. , 1986, Investigative ophthalmology & visual science.
[79] Lloyd Paul Aiello. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. , 2008, Ophthalmology.
[80] K Miyamoto,et al. VEGF increases retinal vascular ICAM-1 expression in vivo. , 1999, Investigative ophthalmology & visual science.
[81] I. Klock,et al. Zonulae adherentes pore size in the external limiting membrane of the rabbit retina. , 1985, Investigative ophthalmology & visual science.
[82] K. Audus,et al. Nitric oxide and blood-brain barrier integrity. , 2001, Antioxidants & redox signaling.
[83] Judy E. Kim,et al. ISIS-DME: A Prospective, Randomized, Dose-Escalation Intravitreal Steroid Injection Study for Refractory Diabetic Macular Edema , 2008, Retina.
[84] M. J. Arnold,et al. Glucose dependence of glycolysis, hexose monophosphate shunt activity, energy status, and the polyol pathway in retinas isolated from normal (nondiabetic) rats. , 1997, Investigative ophthalmology & visual science.
[85] I. Wallow,et al. Permeability and patency of retinal blood vessels in experimental diabetes. , 1977, Investigative ophthalmology & visual science.
[86] W. Mayhan. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. , 1999, American journal of physiology. Cell physiology.
[87] D. R. Anderson,et al. Contractile responses of cultured bovine retinal pericytes to angiotensin II. , 1997, Archives of ophthalmology.
[88] C E Riva,et al. Diffusion of O2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. , 1989, Experimental eye research.
[89] M. Corada,et al. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. , 1998, Journal of cell science.
[90] Ic. Michaelson,et al. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases , 1948 .
[91] L. Rizzolo. Polarity and the development of the outer blood-retinal barrier. , 1997, Histology and histopathology.
[92] Philip J Rosenfeld,et al. Ranibizumab: Phase III clinical trial results. , 2006, Ophthalmology clinics of North America.
[93] Carolyn A. Converse,et al. D-[3H]-galactose incorporation in the bovine retina: specific uptake and transport of the radiolabel in cones. , 1985, Experimental eye research.
[94] W. Foulds,et al. CHEMICAL COMPOSITION OF SUBRETINAL FLUID* , 1962, The British journal of ophthalmology.
[95] M. Dikshit,et al. Nitric oxide-dependent blood-brain barrier permeability alteration in the rat brain , 1996, Experientia.
[96] M. Matsumura,et al. Müller cells in detached human retina express glial fibrillary acidic protein and vimentin , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[97] C T Dollery,et al. Effect of changes in intraocular pressure on the retinal microcirculation. , 1974, The British journal of ophthalmology.
[98] L. Aiello,et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[99] E. Stefánsson,et al. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. , 2001, Acta ophthalmologica Scandinavica.
[100] H. Ikeda,et al. The Effects of Detachment of the Retina on the Induced and Resting Ocular Potentials in the Rabbit , 1966 .
[101] W. R. Lee,et al. PRESSURE EFFECTS ON FLOW CHANNELS IN THE LINING ENDOTHELIUM OF SCHLEMM'S CANAL , 1978, Acta ophthalmologica.
[102] T. Gardner,et al. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. , 2000, Investigative ophthalmology & visual science.
[103] R. Frank,et al. Pericyte coverage of retinal and cerebral capillaries. , 1990, Investigative ophthalmology & visual science.
[104] E. Barrón,et al. Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor. , 2002, Investigative ophthalmology & visual science.
[105] P. Horton,et al. The measurement of the choroidal blood flow in the rabbit using 85-krypton. , 1973, Experimental eye research.
[106] R. Danis,et al. Hyperoxia improves contrast sensitivity in early diabetic retinopathy. , 1996, The British journal of ophthalmology.
[107] C E Riva,et al. Autoregulation of retinal circulation in response to decrease of perfusion pressure. , 1981, Investigative ophthalmology & visual science.
[108] G. Palade,et al. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.
[109] V. Natarajan,et al. Role of Mitogen-activated Protein Kinases in 4-Hydroxy-2-nonenal-induced Actin Remodeling and Barrier Function in Endothelial Cells* , 2004, Journal of Biological Chemistry.
[110] G. Brown,et al. The ocular ischemic syndrome , 1988, International Ophthalmology.
[111] J. Cunha-Vaz,et al. Studies on the permeability of the blood-retinal barrier. IV. Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier. , 1966, Experimental eye research.
[112] Manju Patel,et al. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. , 2006, Ophthalmology.
[113] I. Grierson,et al. POST‐MORTEM CHANGES IN THE RABBIT RETINA , 1976, Acta ophthalmologica.
[114] P. McGuire,et al. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood–retinal barrier , 2005, Laboratory Investigation.
[115] J. Marshall,et al. Human retinal molecular weight exclusion limit and estimate of species variation. , 2003, Investigative ophthalmology & visual science.
[116] E. Rodriguez-Boulan,et al. Apical polarity of Na,K-ATPase in retinal pigment epithelium is linked to a reversal of the ankyrin-fodrin submembrane cytoskeleton , 1991, The Journal of cell biology.
[117] P. Luthert,et al. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. , 2004, Investigative ophthalmology & visual science.
[118] R. Strieter,et al. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. , 1990, The American journal of pathology.
[119] A. Reichenbach,et al. Neuronal versus glial cell swelling in the ischaemic retina. , 2005, Acta ophthalmologica Scandinavica.
[120] G. Fishman,et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. , 1989, Archives of ophthalmology.
[121] C. Kaur,et al. Early response of neurons and glial cells to hypoxia in the retina. , 2006, Investigative ophthalmology & visual science.
[122] J. Schnitzer. Astrocytes in the guinea pig, horse, and monkey retina: Their occurrence coincides with the presence of blood vessels , 1988, Glia.
[123] S. Dudek,et al. Cytoskeletal regulation of pulmonary vascular permeability. , 2001, Journal of applied physiology.
[124] Joan W. Miller,et al. VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization , 2003, The Journal of experimental medicine.
[125] B. Petrig,et al. Retinal blood flow autoregulation in response to an acute increase in blood pressure. , 1986, Investigative ophthalmology & visual science.
[126] J. Alexander,et al. Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins* , 1998, The Journal of Biological Chemistry.
[127] M. Gillies,et al. Effect of Müller cell co-culture on in vitro permeability of bovine retinal vascular endothelium in normoxic and hypoxic conditions , 2005, Neuroscience Letters.
[128] F. Haselton,et al. Partial characterization of the human retinal endothelial cell tight and adherens junction complexes. , 1998, Investigative ophthalmology & visual science.
[129] D. Puro,et al. Energy metabolism in human retinal Müller cells. , 2000, Investigative ophthalmology & visual science.
[130] Y. Hata,et al. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. , 1995, Ophthalmic Research.
[131] L Z Wu,et al. Characteristics of the capillary-free zone in the normal human macula. , 1985, Japanese journal of ophthalmology.
[132] Thomas D. Duane,et al. Biomedical foundations of ophthalmology , 1982 .
[133] R C Hamdy,et al. Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. , 1998, Free radical biology & medicine.
[134] M. Raff,et al. Retinal astrocytes are immigrants from the optic nerve , 1988, Nature.
[135] N. Bressler,et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. , 2007, Ophthalmology.
[136] A. Adamis,et al. Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration. , 2007, Ophthalmology.
[137] D. O. Purtscher. Angiopathia retinae traumatica. Lymphorrhagien des Augengrundes , 1912, Albrecht von Graefes Archiv für Ophthalmologie.
[138] D. Ray,et al. Reversible disruption of tight junction complexes in the rat blood‐brain barrier, following transitory focal astrocyte loss , 2004, Glia.
[139] R K Jain,et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. , 2001, Cancer research.
[140] J Ditzel,et al. Oxygen transport impairment in diabetes. , 1976, Diabetes.
[141] R. Rossi,et al. The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself. , 2001, Free radical biology & medicine.
[142] W. Foulds,et al. Effect of photocoagulation on the barrier function of the pigment epithelium. II. A study by electron microscopy. , 1977, Transactions of the ophthalmological societies of the United Kingdom.
[143] A. Reichenbach,et al. Müller glial cells in anuran retina , 2000, Microscopy research and technique.
[144] C. Futter. The molecular regulation of organelle transport in mammalian retinal pigment epithelial cells. , 2006, Pigment cell research.
[145] M. Shibuya. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis , 2006, Angiogenesis.
[146] R. Heinrikson,et al. Platelet factor 4 is chemotactic for neutrophils and monocytes. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[147] Kazushi Fujimoto,et al. Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin , 1998, The Journal of cell biology.
[148] R. Shivers,et al. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. , 2004, Histology and histopathology.
[149] J. Shelhamer,et al. Takayasu's arteritis and its therapy. , 1985, Annals of internal medicine.
[150] P. Campochiaro,et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. , 2006, American journal of ophthalmology.
[151] J. Jośko,et al. The role of vascular endothelial growth factor in cerebral oedema formation. , 2003, Folia neuropathologica.
[152] B. Damato,et al. Tumour-associated retinal pigment epitheliopathy , 1990, Eye.
[153] C. V. Van Itallie,et al. Tight junctions and the molecular basis for regulation of paracellular permeability. , 1995, The American journal of physiology.
[154] A. Reichenbach,et al. Müller cells as players in retinal degeneration and edema , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[155] C. Achim,et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.
[156] G. Palade,et al. Neovasculature induced by vascular endothelial growth factor is fenestrated. , 1997, Cancer research.
[157] A. Bird,et al. Retinal pigment epithelial detachments in the elderly. , 1986, Transactions of the ophthalmological societies of the United Kingdom.
[158] R. Caldwell,et al. TGF-β increases retinal endothelial cell permeability by increasing MMP-9 : Possible role of glial cells in endothelial barrier function , 2001 .
[159] M. Davis,et al. Clinicopathologic correlations in diabetic retinopathy. I. Histology and fluorescein angiography of microaneurysms. , 1976, Archives of ophthalmology.
[160] H. Ahmadieh,et al. INTRAVITREAL BEVACIZUMAB (AVASTIN) INJECTION ALONE OR COMBINED WITH TRIAMCINOLONE VERSUS MACULAR PHOTOCOAGULATION AS PRIMARY TREATMENT OF DIABETIC MACULAR EDEMA , 2007, Retina.
[161] B. S. Winkler,et al. Cultured retinal neuronal cells and Müller cells both show net production of lactate , 2004, Neurochemistry International.
[162] A. Reichenbach,et al. Expression of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), and Bcl-2 protooncogene protein by Müller (glial) cells in retinal light damage of rats , 1995, Neuroscience Letters.
[163] N. Johnson. Phagocytosis in the normal and ischaemic retinal pigment epithelium of the rabbit. , 1975, Experimental eye research.
[164] M. Simionescu,et al. Transcytosis of plasma macromolecules in endothelial cells: A cell biological survey , 2002, Microscopy research and technique.
[165] D. Armstrong,et al. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. , 1991, Free radical biology & medicine.
[166] J. Marshall,et al. Localization of the site of major resistance to fluid transport in Bruch's membrane. , 1997, Investigative ophthalmology & visual science.
[167] M. Tsacopoulos,et al. Effect of laser photocoagulation on oxygenation of the retina in miniature pigs. , 1985, Investigative ophthalmology & visual science.
[168] Ulrich Schraermeyer,et al. A central role for inflammation in the pathogenesis of diabetic retinopathy , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[169] Michael F. Marmor,et al. The Retinal Pigment Epithelium , 2016 .
[170] E. Ling,et al. Insulin‐like growth factors, angiopoietin‐2, and pigment epithelium–derived growth factor in the hypoxic retina , 2008, Journal of neuroscience research.
[171] A. Levy,et al. The function of hypoxia‐inducible factor 1 (HIF‐1) is impaired in senescent mice , 1999, FEBS letters.
[172] M. Reim,et al. [Rheologic findings in patients with diabetic retinopathy]. , 1991, Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[173] J. Pederson,et al. Acetazolamide effect on the inward permeability of the blood-retinal barrier to carboxyfluorescein. , 1987, Investigative ophthalmology & visual science.
[174] M. Hogan. Role of the retinal pigment epithelium in macular disease. , 1972, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.
[175] M. Spitznas,et al. Increased lipid peroxide level and myeloperoxidase activity in the vitreous of patients suffering from proliferative vitreoretinopathy , 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.
[176] M. Marmor,et al. Quantitative estimation of metabolic transport of subretinal fluid. , 1986, Investigative ophthalmology & visual science.
[177] D. Puro,et al. Physiology of rat retinal pericytes: modulation of ion channel activity by serum‐derived molecules , 1999, The Journal of physiology.
[178] M. Marmor,et al. The effect of metabolic inhibitors on retinal adhesion and subretinal fluid resorption. , 1980, Investigative ophthalmology & visual science.
[179] N. Osborne,et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies , 2004, Progress in Retinal and Eye Research.
[180] Sharon D. Solomon,et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[181] J. Stone,et al. The role of müller cells in the formation of the blood-retinal barrier , 1993, Neuroscience.
[182] Hamid Soltanian-Zadeh,et al. Correlation of VEGF and Angiopoietin Expression with Disruption of Blood–Brain Barrier and Angiogenesis after Focal Cerebral Ischemia , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[183] M. Dubois‐Dauphin,et al. Early postnatal Müller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic mice , 1999, Neuroscience.
[184] M. Cahill,et al. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. , 2003, American journal of ophthalmology.
[185] W. Foulds,et al. Routes of clearance of radioactive water from the rabbit vitreous. , 1984, The British journal of ophthalmology.
[186] Foulds Ws. The local excision of choroidal melanomata. , 1973 .
[187] G. K. Smelser. The structure of the eye , 1961 .
[188] P. Maher,et al. The Regulation of Glucose Metabolism by HIF-1 Mediates a Neuroprotective Response to Amyloid Beta Peptide , 2003, Neuron.
[189] J. Simpson,et al. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. , 2004, Ophthalmology.
[190] M. Marmor. Chapter 112 – Mechanisms of Normal Retinal Adhesion , 2006 .
[191] D. Grover,et al. Intravitreal steroids for macular edema in diabetes. , 2008, The Cochrane database of systematic reviews.
[192] R. H. Steinberg,et al. Transport of taurine, L-methionine and 3-o-methyl-D-glucose across frog retinal pigment epithelium. , 1976, Experimental eye research.
[193] H. Zauberman,et al. Retinal traction in vivo and postmortem. , 1972, Archives of ophthalmology.
[194] T. Rognum,et al. High postmortem levels of hypoxanthine in the vitreous humor of premature babies with respiratory distress syndrome. , 1988, Pediatrics.
[195] N. Eter,et al. Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. , 2008, American journal of ophthalmology.
[196] Frederick W. Fraunfelder. Pegaptanib for wet macular degeneration. , 2005, Drugs of today.
[197] S. Bamforth,et al. Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine. , 1997, The American journal of pathology.
[198] E. Keshet,et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[199] J. Cunha-Vaz,et al. A follow-up study by vitreous fluorophotometry of early retinal involvement in diabetes. , 1978, American journal of ophthalmology.
[200] Peter K Kaiser,et al. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. , 2007, Ophthalmology.
[201] R. Funk,et al. In situ observation of living pericytes in rat retinal capillaries. , 1998, Microvascular research.
[202] C. Pournaras,et al. Light-induced retinal vascular damage by Pd-porphyrin luminescent oxygen probes. , 2005, Investigative ophthalmology & visual science.
[203] M. Wakakura,et al. Response of cultured Müller cells to heat shock--an immunocytochemical study of heat shock and intermediate filament proteins in response to temperature elevation. , 1989, Experimental eye research.
[204] H. Kiyama,et al. Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats , 2001, Diabetologia.
[205] Shoichiro Tsukita,et al. Multifunctional strands in tight junctions , 2001, Nature Reviews Molecular Cell Biology.
[206] R. Cuthbertson,et al. Comparisons of the Intraocular Tissue Distribution, Pharmacokinetics, and Safety of 125I-Labeled Full-Length and Fab Antibodies in Rhesus Monkeys Following Intravitreal Administration , 1999, Toxicologic pathology.
[207] J. Wilkinson-Berka. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. , 2004, Current pharmaceutical design.
[208] D. S. McDevitt. Cell biology of the eye , 1982 .
[209] C. Drea,et al. Influence of early photoreceptor degeneration on lipofuscin in the retinal pigment epithelium. , 1986, Experimental eye research.
[210] C. Graymore. Biochemistry of the retina , 1966 .
[211] J. Dowling. The biologic activity of vitamin A acid. , 1961, The American journal of clinical nutrition.
[212] D. R. Anderson,et al. Effect of CO2 on intracellular pH and contraction of retinal capillary pericytes. , 1997, Investigative ophthalmology & visual science.
[213] M. Goldbaum,et al. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies , 2008, Journal of Clinical Pathology.
[214] P. Oh,et al. Endothelial Caveolae Have the Molecular Transport Machinery for Vesicle Budding, Docking, and Fusion Including VAMP, NSF, SNAP, Annexins, and GTPases (*) , 1995, The Journal of Biological Chemistry.
[215] R. Caldwell,et al. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. , 2003, The American journal of pathology.
[216] M. Boulton,et al. Effects of VEGFR-1, VEGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells. , 2006, Molecular vision.
[217] S. Kaushal,et al. Intravitreal steroids for macular edema: the past, the present, and the future. , 2008, Survey of ophthalmology.
[218] C. Forbes,et al. Blood viscosity in young male diabetics with and without retinopathy , 1980, Diabetologia.
[219] J. Schnitzer. Retinal astrocytes: their restriction to vascularized parts of the mammalian retina , 1987, Neuroscience Letters.
[220] A. Kroll,et al. Experimental retinal detachment in the owl monkey. 3. Electron microscopy of retina and pigment epithelium. , 1968, American journal of ophthalmology.
[221] S. Yoshida,et al. Induction of IL-8, MCP-1, and bFGF by TNF-α in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[222] L. Jampol,et al. The eye in accelerated hypertension. II. Localized serous detachments of the retina in patients. , 1984, Archives of ophthalmology.
[223] J. Simpson,et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. , 2006, Ophthalmology.
[224] A. Cerami,et al. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. , 1986, Clinical chemistry.
[225] P. Grammas,et al. Retinal endothelial cells are more susceptible to oxidative stress and increased permeability than brain-derived endothelial cells. , 2003, Microvascular research.
[226] M. Wakakura,et al. Heat shock response and thermal resistance in cultured human retinal pigment epithelium. , 1993, Experimental eye research.
[227] D. P. Jones,et al. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells. , 2000, Investigative ophthalmology & visual science.
[228] M. Macías-Silva,et al. Assembly and sealing of tight junctions: Possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin , 1991, The Journal of Membrane Biology.
[229] D. Bok,et al. Aquaporin-1 channels in human retinal pigment epithelium: role in transepithelial water movement. , 2003, Investigative ophthalmology & visual science.
[230] B. Burnside,et al. Actin filaments in retinal pericytes and endothelial cells. , 1980, Investigative ophthalmology & visual science.
[231] Edward W. Merrill,et al. Shear Rate Dependence of the Viscosity of Whole Blood and Plasma , 1961, Science.
[232] T. Nakazawa,et al. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. , 2008, American journal of ophthalmology.
[233] D. R. Anderson,et al. Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway. , 1994, Investigative ophthalmology & visual science.
[234] Y. Okada,et al. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. , 2007, The American journal of pathology.
[235] Samantha Fraser-Bell,et al. Update on treatments for diabetic macular edema , 2008, Current opinion in ophthalmology.
[236] P. Campochiaro,et al. TNF-α is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage , 2007, Journal of Neuroimmunology.
[237] A. Barber,et al. Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. , 1997, Investigative ophthalmology & visual science.
[238] K. Csaky,et al. Regulated heat shock protein 27 expression in human retinal pigment epithelium. , 2001, Investigative ophthalmology & visual science.
[239] T. Kawanami,et al. Electron microscopy of the blood‐brain barrier in disease , 1994, Microscopy research and technique.
[240] B. Kirchhof,et al. [Diabetic retinopathy. Pathophysiology and therapy of hypoxia-induced inflammation]. , 2003, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[241] E. Lo,et al. Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation , 2002, Progress in Neurobiology.
[242] G. Jaffe. Thrombospondin as a component of the extracellular matrix of epiretinal membranes: comparisons with cellular fibronectin. , 1994, Survey of ophthalmology.
[243] R. Pokroy,et al. INTRAVITREAL TRIAMCINOLONE FOR DIABETIC MACULAR EDEMA: Comparison of 1, 2, and 4 mg , 2008, Retina.
[244] O. Alonso,et al. Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. , 1994, Journal of neurotrauma.
[245] D. Guyer,et al. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. , 2006, Ophthalmology.
[246] K. Miyarnoto. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .
[247] Michiyasu Suzuki,et al. Cilostazol inhibits the redistribution of the actin cytoskeleton and junctional proteins on the blood-brain barrier under hypoxia/reoxygenation. , 2007, Pharmacological research.
[248] James M. Anderson,et al. Molecular architecture of tight junctions. , 1998, Annual review of physiology.
[249] Francis J. Martin,et al. VEGF-mediated inflammation precedes angiogenesis in adult brain , 2004, Experimental Neurology.
[250] In Koo Hwang,et al. TNF-Related Activation-Induced Cytokine Enhances Leukocyte Adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF Receptor-Associated Factor and Protein Kinase C-Dependent NF-κB Activation in Endothelial Cells1 , 2005, The Journal of Immunology.
[251] M J Hollenberg,et al. Fine structure of the choriocappillaris and retinal capillaries. , 1965, Investigative ophthalmology.
[252] D. Wilson,et al. Macular grid photocoagulation. An experimental study on the primate retina. , 1988, Archives of ophthalmology.
[253] A. Reichenbach,et al. Hypoxia: modulation of endothelial cell proliferation by soluble factors released by retinal cells , 2001, Neuroreport.
[254] P. Röhlich. The interphotoreceptor matrix: electron microscopic and histochemical observations on the vertebrate retina. , 1970, Experimental eye research.
[255] Hyung Jin Kim,et al. Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-κB Activation in Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[256] P. Campochiaro,et al. Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[257] Carolyn A. Converse,et al. D-[3H]galactose incorporation into glycogen in retinal cone cells. , 1990, Experimental eye research.
[258] A. Iannaccone,et al. Pigment epithelium‐derived factor supports normal Müller cell development and glutamine synthetase expression after removal of the retinal pigment epithelium , 2001, Glia.
[259] D. Cogan,et al. Retinal vascular patterns. VI. Mural cells of the retinal capillaries. , 1963, Archives of ophthalmology.
[260] W. Schaper,et al. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. , 2002, Microvascular research.
[261] W. Lee,et al. Basal linear deposit in the human macula , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[262] E. Rodriguez-Boulan,et al. Apical polarization of N-CAM in retinal pigment epithelium is dependent on contact with the neural retina , 1993, The Journal of cell biology.
[263] D. Drubin,et al. Origins of Cell Polarity , 1996, Cell.
[264] J. Weiter,et al. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. , 1978, Investigative ophthalmology & visual science.
[265] D. Fei,et al. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. , 2005, Investigative ophthalmology & visual science.
[266] I. Wallow,et al. Endothelial fenestrae in proliferative diabetic retinopathy. , 1980, Investigative ophthalmology & visual science.
[267] M. Zimmerman,et al. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. , 1994, American journal of ophthalmology.
[268] E. Mackenzie,et al. The response of the choroidal and cerebral circulations to changing arterial PCO2 and acetazolamide in the baboon. , 1977, Investigative ophthalmology & visual science.
[269] W. Foulds,et al. Tracer Movement Across the Rabbit Retina , 1981 .
[270] W S Foulds,et al. Observations on the retinal pigment epithelium and retinal macrophages in experimental retinal detachment. , 1977, The British journal of ophthalmology.
[271] Foulds Ws. Aetiology of retinal detachment. , 1975 .
[272] W. Foulds. The choroidal circulation and retinal metabolism—An overview , 1990, Eye.
[273] N. Ashton,et al. OCULAR PATHOLOGY IN MACROGLOBULINAEMIA. , 1963, The Journal of pathology and bacteriology.
[274] R. Sidman. HISTOCHEMICAL STUDIES ON PHOTORECEPTOR CELLS , 1958, Annals of the New York Academy of Sciences.
[275] R. Sercombe,et al. Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions. , 1996, Cerebrovascular and brain metabolism reviews.
[276] P. Campochiaro,et al. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema , 2004, Documenta Ophthalmologica.
[277] C. Distler,et al. Glia Cells of the Monkey Retina—II. Müller Cells , 1996, Vision Research.
[278] I. Fatt,et al. Flow conductivity of retina and its role in retinal adhesion. , 1971, Experimental eye research.
[279] Kang Zhang,et al. Mutant carbonic anhydrase 4 impairs pH regulation and causes retinal photoreceptor degeneration. , 2005, Human molecular genetics.
[280] M. Parodi,et al. Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: a pilot study , 2008, British Journal of Ophthalmology.
[281] C. Forbes,et al. Increased blood viscosity in diabetic proliferative retinopathy. , 1986, Diabetes research.
[282] W. Sluiter,et al. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. , 1993, Journal of cardiovascular pharmacology.
[283] N. Philp,et al. Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells. , 2003, Investigative ophthalmology & visual science.
[284] Sharon D. Solomon,et al. Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. , 2004, Archives of ophthalmology.
[285] B. Gong,et al. Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. , 2007, Investigative ophthalmology & visual science.
[286] Bernd Kirchhof,et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. , 2002, The American journal of pathology.
[287] M. Marmor,et al. The rate and source of albumin entry into saline-filled experimental retinal detachments. , 1994, Investigative ophthalmology & visual science.
[288] P. Rosenfeld,et al. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2006, Ophthalmology.
[289] W. Foulds,et al. Effect of photocoagulation on the barrier function of the pigment epithelium. I. A study by fluorescein angiography. , 1977, Transactions of the ophthalmological societies of the United Kingdom.
[290] E. Oldfield,et al. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. , 1999, Journal of neuropathology and experimental neurology.
[291] J. Jośko,et al. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[292] D. R. Anderson,et al. Adenosine-induced relaxation of cultured bovine retinal pericytes. , 1997, Investigative ophthalmology & visual science.